Evaluation of Anti-Xa Apixaban and Rivaroxaban Levels With Respect to Known Doses in Relation to Major Bleeding Events

Steffany N. Nguyen, Melanie C. Ruegger, Eric Salazar, Diane Dreucean, Alexandra W. Tatara, Kevin R. Donahue

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Evaluation of Anti-Xa Apixaban and Rivaroxaban Levels With Respect to Known Doses in Relation to Major Bleeding Events'. Together they form a unique fingerprint.

Chemistry

Medicine & Life Sciences